(Q48402858)

11 February 2018

title

Modulation of central serotonergic neurotransmission by risperidone: underlying mechanism(s) and significance of action (English)

1 reference

11 February 2018

1 reference

Hertel P

1

1 reference

11 February 2018

Lindblom N

series ordinal

2

1 reference

11 February 2018

Nomikos GG

series ordinal

3

1 reference

11 February 2018

Svensson TH

series ordinal

4

1 reference

11 February 2018

publication date

1 July 1998

1 reference

11 February 2018

Progress in Neuro-Psychopharmacology & Biological Psychiatry

published in

1 reference

11 February 2018

volume

22

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

page(s)

815-834

1 reference

11 February 2018

The role of serotonin in the pathophysiology and treatment of schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Studies on RX 781094: a selective, potent and specific antagonist of α2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Idazoxan (RX 781094) selectively antagonizes α2-adrenoceptors on rat central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Adjunctive fluoxetine improves global function in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Structure and function of the brain serotonin system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Prazosin selectively antagonizes neuronal responses mediated by ?1-adrenoceptors in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Modulation of neurotransmitter release by presynaptic autoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

Collateral inhibition of serotonergic neurones in the rat dorsal raphe nucleus: Pharmacological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900042-6

7 January 2021

10.1016/S0278-5846(98)00042-6

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018